Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome

The treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become available, reporting the side effects of these agents in clinical practice becomes increasingly important. Nivolumab is one of the chemotherapeutic agents commonly used for treatment of renal cell carcinoma,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaucer, Benjamin, Stone, Abriella, Demanes, Augustus, Seibert, Shawn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822822/
https://www.ncbi.nlm.nih.gov/pubmed/29593922
http://dx.doi.org/10.1155/2018/4273231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822822/
https://www.ncbi.nlm.nih.gov/pubmed/29593922
http://dx.doi.org/10.1155/2018/4273231

Ejemplares similares